Status:
COMPLETED
Early-warning Intervention for Heat and Cold in Older Hypertensive Patients: Impact on Blood Pressure and ECG
Lead Sponsor:
Tiantian Li
Conditions:
Hypertension
Eligibility:
All Genders
60-65 years
Phase:
NA
Brief Summary
This cluster-randomized trial, conducted in Tianjin, China, aims to evaluate the effectiveness of integrating a digital health risk early warning tool for heat with self-monitoring. Additionally, the ...
Detailed Description
This cluster-randomized trial will be conducted in various districts across Tianjin, China. As part of the early warning interventions for heat and cold, three communities from each of the two selecte...
Eligibility Criteria
Inclusion
- Individuals aged 60 to 65 years Individuals with a diagnosis of hypertension Individuals with untreated blood pressure above 140/90 mm Hg
Exclusion
- Having a history of coronary heart disease, heart failure, or stroke Unable to cooperate with follow-up
Key Trial Info
Start Date :
July 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2024
Estimated Enrollment :
342 Patients enrolled
Trial Details
Trial ID
NCT06011213
Start Date
July 1 2023
End Date
February 28 2024
Last Update
January 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Environmental Health, Chinese Center for Disease Control and Prevention
Beijing, China, 100021